Suppliers / Minakem High Potent

Minakem High Potent

Belgium Updated 9 July 2026

Minakem High Potent is an API manufacturer based in Belgium. It holds 3 active US drug master files and 4 valid CEPs across a filed portfolio of 3 molecules. Its most recent recorded inspection, by US FDA, closed on 19 April 2023 as VAI.

3
active US DMFs
4
valid CEPs
4
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 19 April 2023 VAI US FDA
  • 6 February 2020 VAI US FDA
  • 24 September 2015 NAI US FDA
  • 12 January 2012 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Mont-Saint-Guibert, Belgium Not on file
Corbais, Belgium Not on file
Mont-St-Guibert, Belgium Not on file
Belgium, Belgium 3002807801

What they file, and where

Molecule Regulators Docs
Vinblastine EDQM, US FDA 3
Vincristine EDQM, US FDA 2
Vinorelbine EDQM, US FDA 2

Also appears on these molecule pages

Vincristine API Vinorelbine API

Comparing suppliers?

Choose your molecules and target markets. Minakem High Potent comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 19 April 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability